Caligenix

Company Overview

Snapshot

Founded in August 2014 by Dr. Tzur Gabi and Eliad Josephson, Caligenix operates with 1–10 employees. The company has raised $720,000 across one funding round from one investor. In May 2021, Caligenix announced plans to launch personalized skincare and nutrition brands leveraging real-time RNA.

Business overview

Caligenix is a biotechnology company focused on developing personalized genomic diagnostic kits. The company's core technology involves understanding the link between genetic variation, individual dietary response, and the role of nutrients in gene expression. Caligenix offers two primary products: the Health and Wellness test for general public optimization and the Sports test for enhancing performance and decreasing injury risk. These simple saliva tests are processed in CLIA-certified and CAP-accredited labs, providing personalized reports. The company serves B2B clients, enabling them to customize health and wellness offerings based on genomic data, operating within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Digital Therapeutics.

Strategic signal

In May 2021, Caligenix announced its intention to launch personalized skincare and nutrition brands, leveraging real-time RNA technology. This strategic move signals the company's expansion beyond its initial diagnostic kits into direct consumer-facing products, indicating a potential shift towards broader market applications and a more integrated approach to personalized wellness.

Company Intelligence Q&A

What is Caligenix's primary focus?

Caligenix is a biotechnology company that develops personalized genomic diagnostic kits to understand the link between genetic variation, individual dietary response, and nutrient's role in gene expression.

When was Caligenix founded and by whom?

Caligenix was founded in August 2014 by Dr. Tzur Gabi and Eliad Josephson.

What products does Caligenix currently offer?

Caligenix currently offers two tests: the Caligenix Health and Wellness test for general health optimization and the Caligenix Sports test for enhancing athletic performance and reducing injury risk. The company also launched Immunotype in December 2020, entering the nutritional supplement space.

What was a significant product development announced by Caligenix in 2021?

In May 2021, Caligenix announced plans to launch personalized skincare and nutrition brands, leveraging real-time RNA technology.

How much capital has Caligenix raised?

Caligenix has raised $720,000 across one funding round.